ResMed Inc. Files 8-K for Operations and Financials

Ticker: RSMDF · Form: 8-K · Filed: Apr 25, 2024 · CIK: 943819

Resmed Inc 8-K Filing Summary
FieldDetail
CompanyResmed Inc (RSMDF)
Form Type8-K
Filed DateApr 25, 2024
Risk Levellow
Pages2
Reading Time2 min
Key Dollar Amounts$0.004, $0.48
Sentimentneutral

Sentiment: neutral

Topics: financial-reporting, operations, sec-filing

Related Tickers: RMD

TL;DR

ResMed dropped an 8-K detailing financials and other events. Check it out.

AI Summary

ResMed Inc. filed an 8-K on April 25, 2024, to report on its results of operations and financial condition, as well as other events. The filing also includes financial statements and exhibits. The company is incorporated in Delaware and its principal executive offices are located in San Diego, California.

Why It Matters

This 8-K filing provides investors with crucial updates on ResMed's financial performance and significant business events, impacting their investment decisions.

Risk Assessment

Risk Level: low — This filing is a standard 8-K reporting routine financial and operational information, not indicating any immediate or unusual risks.

Key Players & Entities

  • RESMED INC (company) — Registrant
  • Delaware (jurisdiction) — State of Incorporation
  • San Diego, California (location) — Principal Executive Offices
  • April 25, 2024 (date) — Date of Report

FAQ

What is the primary purpose of this 8-K filing for ResMed Inc.?

The primary purpose of this 8-K filing is to report on ResMed Inc.'s results of operations and financial condition, as well as other events, and to include financial statements and exhibits.

When was this 8-K filing submitted?

This 8-K filing was submitted on April 25, 2024.

Where are ResMed Inc.'s principal executive offices located?

ResMed Inc.'s principal executive offices are located at 9001 Spectrum Center Blvd., San Diego, California.

In which U.S. state is ResMed Inc. incorporated?

ResMed Inc. is incorporated in Delaware.

What is the SIC code associated with ResMed Inc.'s industry?

The Standard Industrial Classification (SIC) code associated with ResMed Inc. is 3841, which corresponds to Surgical & Medical Instruments & Apparatus.

Filing Stats: 613 words · 2 min read · ~2 pages · Grade level 9.8 · Accepted 2024-04-25 16:07:05

Key Financial Figures

  • $0.004 — ange on which registered Common Stock, $0.004 par value RMD NYSE Indicate by che
  • $0.48 — eclared a quarterly cash dividend of US $0.48 per share. The dividend will have a rec

Filing Documents

Financial Statements and Exhibits

Financial Statements and Exhibits. (d)Exhibits Exhibits: Description of Document 99.1 Press Release dated April 25, 2024, regarding results of operations 104 Cover Page Interactive Data File (embedded within the Inline XBRL, document) -2-

SIGNATURES

SIGNATURES We have authorized the person whose signature appears below to sign this report on our behalf, in accordance with the Securities Exchange Act of 1934. Date: April 25, 2024 RESMED INC. (registrant) By: /s/ Brett Sandercock Name: Brett Sandercock Its: Chief Financial Officer -3-

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.